Michael Hwang

3PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette, Lisa Licitra, Kevin Harrington

|May 06, 2023
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab.

Weifeng Tang, Raj Tummala, Joachim Almquist

Pageof 1